A person suspected in a Plano homicide investigation led authorities on a car chase Monday that ended in a fiery crash and standoff on Interstate 35 near the border of Denton and Cooke counties, ...

Esta pagina reproduz o sinal publicado pelo encoder Datavideo NVS-35 diretamente no servidor de testes da Zeus Broadcast, sem passar pelo Wowza da TV Guarapari. RTMP ...

Novartis (NVS) shares closed lower for the third straight session on Wednesday after Deutsche Bank downgraded the Swiss drugmaker, citing recent failures in a pair of its late-stage trials that sent ...

Novartis AG (NYSE:NVS) could be staring at a $3 billion annual peak-sales opportunity in multiple sclerosis (MS) if its drug remibrutinib successfully advances through the regulatory process and gains ...

On the professional dancer side, 'The Next Pro' judge Mark Ballas returns while season 34 troupe member Hailey Bills was promoted to pro in the third-ever same-sex 'DWTS' pairing. By McKinley Franklin ...

Novartis (NVS) traded higher on Tuesday after remibrutinib, its FDA-approved treatment for a skin condition known as "hives," succeeded in two Phase 3 trials for patients with multiple sclerosis, a ...

The results for the Eklavya Model Residential Schools will be declared separately. CBSE Recruitment: The Central Board of Secondary Education (CBSE) has announced in an official notification that it ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Novartis' acquisition of U.S.-based Excellergy will add an early-stage drug candidate Exl-111 to the company's existing allergy portfolio. It comes just a week after Novartis announced it is acquiring ...

The idea that the chances of getting pregnant plummet at 35 is widespread. But it’s not totally true. By Dani Blum One number is inescapable for women who want children: 35. Give birth at that age or ...

Novartis announced late Monday that the U.S. Food and Drug Administration (FDA) approved its Itvisma for certain forms of spinal muscular atrophy (SMA). The healthcare company didn't hesitate to ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. President Donald Trump has announced he will greenlight the sale of ...